As the Centers for Medicare and Medicaid Services calls for public feedback on how to stop lab test fraud, experts say a tailored regulatory strategy will be key to avoid stifling innovation.

What appeared to be a surge of grassroots support for higher Medicare Advantage payments was actually driven by a pro-industry group.

A newly formed EMS Review Committee is exploring shifting ambulance duties from a private company to the Elyria Fire Department.

Medicare Advantage insurers say a proposal by the Trump administration to keep their payments nearly flat next year may lead to service cuts that harm seniors struggling to afford health care. A ...

Eli Lilly LLY, a dominant player in the global obesity market, derives most of its revenues from its blockbuster GLP-1 medicines, Mounjaro for type II diabetes (T2D) and Zepbound for obesity. Despite ...

Rampant Medicare fraud schemes in Los Angeles allegedly bilk taxpayers for billions through fake home health agencies and ghost patients across the city.

Don't assume it's the most cost-effective option.

Consumers filed over 200 complaints with some telemedicine companies for misleading customers about costs of weight loss using GLP-1 drugs.

The government’s $2 billion revenue target might be at risk as people like Michael Finger and Brian Rodricks plan to beat the ...